+91 94997 68112

What is Pharmalysis?

Pharmalysis offers the essence of both the databases in the form of highly actionable reports. The reports offer insightful intelligence and are forward looking.

Para IV Winners and Losers

A Monthly report that highlights all the important developments in the Para IV space for a given month. It also offers forecast of launch timelines for each generics

Thu Sep, 2023 | Pharmalysis

Low Competition Approvals

A Weekly report that enlists all approvals with less than 4 generic competition along with the possible timeline of such low competition products

Thu Sep, 2023 | Pharmalysis

New Suitability Petitions

A Quarterly report that identifies Suitability Filings for that quarter. It also offers insight into the possible alterations proposed in the filing.

Thu Sep, 2023 | Pharmalysis

Impact Analyses

Analyses of GMP actions by USFDA on the manufacturer facing the action and likely impact (beneficial) of the same to other competing manufacturers. This report is Event based

Thu Sep, 2023 | Pharmalysis

Generic Drug Price Changes_MoM

This report captures the dosage wise monthly change in drug pricing in the US generics market.

Wed Feb, 2024 | Pharmalysis

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact

Pharmalysis

What is Pharmalysis?

Para IV Winners and Losers

Low Competition Approvals

New Suitability Petitions

Impact Analyses

Generic Drug Price Changes_MoM

Headquarters

Products & Services

Quick Links